S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review

Abstract Phospho‐ribosyl‐pyrophosphate synthetase 1 (PRPS1) deficiency is secondary to loss of function variants in PRPS1. This enzyme generates phospho‐ribosyl‐pyrophosphate (PRPP), which is utilized in the synthesis of purines, nicotinamide adenine dinucleotide (NAD), and NAD phosphate (NADP), amo...

Full description

Bibliographic Details
Main Authors: Angela Lee, Renatta Knox, Margaret Reynolds, Erin McRoy, Hoanh Nguyen
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:JIMD Reports
Subjects:
Online Access:https://doi.org/10.1002/jmd2.12395
_version_ 1797640024564432896
author Angela Lee
Renatta Knox
Margaret Reynolds
Erin McRoy
Hoanh Nguyen
author_facet Angela Lee
Renatta Knox
Margaret Reynolds
Erin McRoy
Hoanh Nguyen
author_sort Angela Lee
collection DOAJ
description Abstract Phospho‐ribosyl‐pyrophosphate synthetase 1 (PRPS1) deficiency is secondary to loss of function variants in PRPS1. This enzyme generates phospho‐ribosyl‐pyrophosphate (PRPP), which is utilized in the synthesis of purines, nicotinamide adenine dinucleotide (NAD), and NAD phosphate (NADP), among other metabolic pathways. Arts syndrome, or severe PRPS1 deficiency, is an X‐linked condition characterized by congenital sensorineural hearing loss, optic atrophy, developmental delays, ataxia, hypotonia, and recurrent infections that can cause progressive clinical decline, often resulting in death before 5 years of age. Supplementation of the purine and NAD pathways outside of PRPP‐dependent reactions is a logical approach and has been reported in a handful of patients, two with S‐adenosylmethionine (SAMe) and one with SAMe and nicotinamide riboside (NR). We present the clinical course of a fourth Arts syndrome patient who was started on therapy and review previously reported patients. All patients had stability or improvement of symptoms, suggesting that SAMe and NR can be a treatment option in Arts syndrome, though further studies are warranted.
first_indexed 2024-03-11T13:25:59Z
format Article
id doaj.art-f4215bb5b6d6428aaa4b3f1ab9d236a2
institution Directory Open Access Journal
issn 2192-8312
language English
last_indexed 2024-03-11T13:25:59Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series JIMD Reports
spelling doaj.art-f4215bb5b6d6428aaa4b3f1ab9d236a22023-11-03T07:45:49ZengWileyJIMD Reports2192-83122023-11-0164641742310.1002/jmd2.12395S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature reviewAngela Lee0Renatta Knox1Margaret Reynolds2Erin McRoy3Hoanh Nguyen4Department of Pediatrics, Division of Genetics and Genomic Medicine Washington University Saint Louis Missouri USADepartment of Pediatrics and Neurology Washington University Saint Louis Missouri USADepartments of Pediatrics, Division of Ophthalmology Washington University Saint Louis Missouri USADepartment of Pediatrics, Division of Genetics and Genomic Medicine Washington University Saint Louis Missouri USADepartment of Pediatrics, Division of Genetics and Genomic Medicine Washington University Saint Louis Missouri USAAbstract Phospho‐ribosyl‐pyrophosphate synthetase 1 (PRPS1) deficiency is secondary to loss of function variants in PRPS1. This enzyme generates phospho‐ribosyl‐pyrophosphate (PRPP), which is utilized in the synthesis of purines, nicotinamide adenine dinucleotide (NAD), and NAD phosphate (NADP), among other metabolic pathways. Arts syndrome, or severe PRPS1 deficiency, is an X‐linked condition characterized by congenital sensorineural hearing loss, optic atrophy, developmental delays, ataxia, hypotonia, and recurrent infections that can cause progressive clinical decline, often resulting in death before 5 years of age. Supplementation of the purine and NAD pathways outside of PRPP‐dependent reactions is a logical approach and has been reported in a handful of patients, two with S‐adenosylmethionine (SAMe) and one with SAMe and nicotinamide riboside (NR). We present the clinical course of a fourth Arts syndrome patient who was started on therapy and review previously reported patients. All patients had stability or improvement of symptoms, suggesting that SAMe and NR can be a treatment option in Arts syndrome, though further studies are warranted.https://doi.org/10.1002/jmd2.12395Arts syndromenicotinamide ribosidephosphoribosylpyrophosphatePRPPPRPS1S‐adenosylmethionine
spellingShingle Angela Lee
Renatta Knox
Margaret Reynolds
Erin McRoy
Hoanh Nguyen
S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
JIMD Reports
Arts syndrome
nicotinamide riboside
phosphoribosylpyrophosphate
PRPP
PRPS1
S‐adenosylmethionine
title S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
title_full S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
title_fullStr S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
title_full_unstemmed S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
title_short S‐adenosylmethionine and nicotinamide riboside therapy in Arts syndrome: A case report and literature review
title_sort s adenosylmethionine and nicotinamide riboside therapy in arts syndrome a case report and literature review
topic Arts syndrome
nicotinamide riboside
phosphoribosylpyrophosphate
PRPP
PRPS1
S‐adenosylmethionine
url https://doi.org/10.1002/jmd2.12395
work_keys_str_mv AT angelalee sadenosylmethionineandnicotinamideribosidetherapyinartssyndromeacasereportandliteraturereview
AT renattaknox sadenosylmethionineandnicotinamideribosidetherapyinartssyndromeacasereportandliteraturereview
AT margaretreynolds sadenosylmethionineandnicotinamideribosidetherapyinartssyndromeacasereportandliteraturereview
AT erinmcroy sadenosylmethionineandnicotinamideribosidetherapyinartssyndromeacasereportandliteraturereview
AT hoanhnguyen sadenosylmethionineandnicotinamideribosidetherapyinartssyndromeacasereportandliteraturereview